To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for an active research protocol. Open-ended [clinicaltrials_resource:24d2f101f1e2fa0fd47034cd294142fe]
NIH Clinical Center Detailed Web Page
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for an active research protocol. Open-ended [clinicaltrials_resource:24d2f101f1e2fa0fd47034cd294142fe]
NIH Clinical Center Detailed Web Page
Bio2RDF identifier
24d2f101f1e2fa0fd47034cd294142fe
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:24d2f101f1e2fa0fd47034cd294142fe
measure [clinicaltrials_vocabulary:measure]
To provide continuing treatmen ...... r an active research protocol.
time frame [clinicaltrials_vocabulary:time-frame]
Open-ended
description
NIH Clinical Center Detailed Web Page
identifier
clinicaltrials_resource:24d2f101f1e2fa0fd47034cd294142fe
title
To provide continuing treatmen ...... research protocol. Open-ended
@en
type
label
To provide continuing treatmen ...... 2f101f1e2fa0fd47034cd294142fe]
@en